Biblio
Found 64 results
Filters: Author is Vanderah, Todd W  [Clear All Filters]
.  
2018.  Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.. eNeuro. 5(4)
.  
2018.  Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.. Pain. 159(9):1814-1823.
.  
2017.  Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.. Br J Pharmacol. 
.  
2017.  Long-lasting antinociceptive effects of green light in acute and chronic pain in rats.. Pain. 158(2):347-360.
.  
2017.  Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury.. J Trauma Acute Care Surg. 
.  
2017.  Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.. Neuropharmacology. 116:59-70.
.  
2017.  Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.. Pain. 158(9):1733-1742.
.  
2016.  Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.. Pain. 157(12):2709-2721.
.  
2016.  The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.. Pain. 157(11):2605-2616.
.  
2016.  Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.. Bioorg Med Chem Lett. 26(1):222-7.
.  
2016.  Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor.. J Med Chem. 59(22):10291-10298.
.  
2015.  Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors.. Receptors Clin Investig. 2(1)
.  
2015.  Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.. Bioorg Med Chem Lett. 25(20):4683-8.
.  
2015.  Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.. Bioorg Med Chem. 23(18):6185-94.
.  
2015.  Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.. J Med Chem. 58(21):8573-83.
.  
2015.  Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.. Brain. 138(Pt 1):28-35.
.  
2015.  Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.. J Pharmacol Exp Ther. 352(3):462-70.
.  
2015.  Therapeutic potential of peroxynitrite decomposition catalysts: a patent review.. Expert Opin Ther Pat. :1-24.
.  
2015.  Use of Animal Models in Understanding Cancer-induced Bone Pain.. Cancer Growth Metastasis. 8(Suppl 1):47-62.
.  
2014.  Animal models for opioid addiction drug discovery.. Expert Opin Drug Discov. 9(11):1345-54.
.  
2014.  Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord.. J Am Chem Soc. 136(18):6608-16.
.  
2013.  Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.. J Bone Miner Res. 28(1):92-107.
.  
2013.  Effect of anchoring 4-anilidopiperidines to opioid peptides.. Bioorg Med Chem Lett. 23(11):3434-7.
.  
2013.  Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.. Life Sci. 93(25-26):1010-6.
